When Big Money Meets Healthcare: A Closer Look at New York’s Medicaid Mess

The Program Designed to Help Now in the Crosshairs

New York’s Consumer Directed Personal Assistance Program (CDPAP) was meant to empower elderly and disabled patients—and the families who care for them—by letting them hire their own caregivers. But what started as a lifeline for over 460,000 people may have become a lucrative side deal for one company, Public Partnerships LLC (PPL), accused of exploiting systemic flaws.

The Allegations: Overcharging, Backroom Deals, and a Billion-Dollar Question

Federal prosecutors have taken New York to court, alleging that instead of fixing inefficiencies, state officials colluded with PPL to push through a contract that siphoned millions from a program meant for real care.

• Overcharging at Scale? The U.S. claims PPL was handpicked early and then overbilled the state for services, draining funds that should have gone to patients and caregivers.
• Blocked Competition? New York’s own Medicaid director, Amir Bassiri, allegedly shut out other bidders, with emails suggesting pressure from higher-ups—possibly even the governor’s office.
• Billions Disputed New York insists the switch to PPL saved taxpayers over a billion dollars by cutting waste. The feds say excess profits piled up instead, funneling money away from those who needed it most.

Who’s Really in Charge? Money, Politics, or Patient Care?

The core of the dispute isn’t just about dollars—it’s about who controls the system.

• New York’s Defense: The state calls the lawsuit election-year politics, framing the move as an attack on a program that saved money.
• The Feds’ Stance: Prosecutors call it plain fraud, arguing that power and profit took precedence over the people the program was meant to serve.
• The Human Cost: Sandwiched between legal battles, patients and caregivers wait, unsure if the system will ever put their needs first.

What Happens Next?

The lawsuit forces a reckoning: Was CDPAP fixed—or exploited? And if profits were prioritized over care, who ultimately bears the cost?

One thing is clear—the most vulnerable are still waiting for answers.